384 related articles for article (PubMed ID: 15490982)
1. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.
Goffin E; Herbiet L; Pouthier D; Pochet JM; Lafontaine JJ; Christophe JL; Gigi J; Vandercam B
Perit Dial Int; 2004; 24(5):433-9. PubMed ID: 15490982
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.
Demoulin N; Goffin E
Perit Dial Int; 2009; 29(5):548-53. PubMed ID: 19776049
[TBL] [Abstract][Full Text] [Related]
4. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
5. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis.
Lee CC; Sun CY; Chang KC; Wu MS
Ther Apher Dial; 2010 Apr; 14(2):201-8. PubMed ID: 20438543
[TBL] [Abstract][Full Text] [Related]
6. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
[TBL] [Abstract][Full Text] [Related]
7. Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades.
Fontán MP; Cambre HD; Rodríguez-Carmona A; Muñiz AL; Falcón TG
Perit Dial Int; 2009; 29(3):310-8. PubMed ID: 19458304
[TBL] [Abstract][Full Text] [Related]
8. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Heywood A; Bargman JM
Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
[TBL] [Abstract][Full Text] [Related]
9. The need for a center-tailored treatment protocol for peritonitis.
Van Biesen W; Vanholder R; Vogelaers D; Peleman R; Verschraegen G; Vijt D; Lameire N
Perit Dial Int; 1998; 18(3):274-81. PubMed ID: 9663891
[TBL] [Abstract][Full Text] [Related]
10. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
Blunden M; Zeitlin D; Ashman N; Fan SL
Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
[TBL] [Abstract][Full Text] [Related]
11. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
[TBL] [Abstract][Full Text] [Related]
12. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?
Kan GW; Thomas MA; Heath CH
Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199
[TBL] [Abstract][Full Text] [Related]
13. Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Oliveira LG; Luengo J; Caramori JC; Montelli AC; Cunha Mde L; Barretti P
Int Urol Nephrol; 2012 Oct; 44(5):1529-37. PubMed ID: 22302733
[TBL] [Abstract][Full Text] [Related]
14. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility.
Persy B; Ieven M
Acta Clin Belg; 2013; 68(1):48-53. PubMed ID: 23627195
[TBL] [Abstract][Full Text] [Related]
15. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
Goldberg L; Clemenger M; Azadian B; Brown EA
Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Goffin E; Pouthier D; Vandercam B; Gigi J; van Ypersele de Strihou C
Clin Nephrol; 1997 Dec; 48(6):391-2. PubMed ID: 9438101
[No Abstract] [Full Text] [Related]
17. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
Krothapalli RK; Senekjian HO; Ayus JC
Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
[TBL] [Abstract][Full Text] [Related]
18. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
[TBL] [Abstract][Full Text] [Related]
19. Peritonitis in children with automated peritoneal dialysis: a single-center study of a 10-year experience.
Dotis J; Myserlis P; Printza N; Stabouli S; Gkogka C; Pavlaki A; Papachristou F
Ren Fail; 2016 Aug; 38(7):1031-5. PubMed ID: 27185324
[TBL] [Abstract][Full Text] [Related]
20. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
